Mesa Laboratories Net Profit Margin 2010-2025 | MLAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Mesa Laboratories net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Mesa Laboratories net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185B
Thermo Fisher Scientific (TMO)	$160.4B
Edwards Lifesciences (EW)	$44.7B
Alcon (ALC)	$42.9B
IDEXX Laboratories (IDXX)	$41.7B
DexCom (DXCM)	$33B
IQVIA Holdings (IQV)	$28.2B
Mettler-Toledo (MTD)	$25.1B
STERIS (STE)	$22.1B
Waters (WAT)	$17.7B
SONOVA HOLDING (SONVY)	$17B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.6B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Globus Medical (GMED)	$7.8B
Glaukos (GKOS)	$5.7B
Teleflex (TFX)	$5B
Integer Holdings (ITGR)	$4B
TransMedics (TMDX)	$3.8B
PROCEPT BioRobotics (PRCT)	$3.3B
LivaNova (LIVN)	$2.3B
Nihon Kohden (NHNKY)	$2B
Veracyte (VCYT)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1.1B